Public health research literature on infectious diseases: coverage and gaps in Europe.

BACKGROUND In this study, bibliometric methods were used to investigate prevention and control of infectious diseases (IDs). The aim was to gain an overall view of published research on IDs in Europe as part of the collaborative study SPHERE (Strengthening Public Health Research in Europe). METHODS A framework for research on IDs and public health was developed with definitions, keywords, inclusion and exclusion criteria. A detailed web search strategy based on the framework was designed, piloted and refined. The PubMed electronic database was searched for 'infectious diseases' as a whole, and for several subtopic areas, across July 1995 and June 2005. Numbers of publications by year, country, population and Gross Domestic Product were calculated. RESULTS Nearly 21,000 publications on the main topic and sub-topics were found, with a progressive increase particularly since 2000. There was a marked heterogeneity between countries. France, Italy, The Netherlands, Spain, Germany, Switzerland, Sweden, UK and Belgium were the most prolific, and Eastern European countries less so. 'Vaccine-preventable diseases', 'Sexually transmitted diseases', 'Drug-resistant infections', 'Insect-arthropod-related diseases' and 'Childhood diseases' were the main fields of scientific production. Research on 'Epidemiology and Surveillance' appeared, in general, to be better represented than research on 'Prevention and Control'. DISCUSSION This is the first time such a broad approach has been used to describe public health research on IDs across Europe. A priority should be cooperation between European states where there is little or no, scientific production. Bibliometrics has limitations, but is of value to indicate a general pattern.

[1]  R. Finch,et al.  Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. , 2006, The Journal of antimicrobial chemotherapy.

[2]  S. Salmaso,et al.  Epidemiology of tetanus in Italy in years 1971-2000. , 2002, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  A. Zanetti,et al.  Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003). , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  K. Cartwright.  Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management , 2002, European Journal of Pediatrics.

[5]  H. Stiver,et al.  The threat and prospects for control of an influenza pandemic , 2004, Expert review of vaccines.

[6]  C. Grose.  Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  Vicente Navarro,et al.  The Political Context of Social Inequalities and Health , 2001, International journal of health services : planning, administration, evaluation.

[8]  R. Leke,et al.  Certification of polio eradication: process and lessons learned. , 2004, Bulletin of the World Health Organization.

[9]  J. Sterne,et al.  Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies , 2003, The Lancet.

[10]  A. Zanetti,et al.  Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003). , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  W. H. Hattie.  DIPHTHERIA TOXOID. , 1927, Canadian Medical Association journal.

[12]  J. Wilkinson.  European Observatory on Health Care Systems Series , 2006 .

[13]  A. Hinman,et al.  Immunisation practice in developed countries , 1990, The Lancet.

[14]  Charles Levenstein,et al.  Work and Health in the Global Economy: Lessons from Developing and Industrialized Countries on the Impact of Work on Health , 2002, New solutions : a journal of environmental and occupational health policy : NS.

[15]  M. Marmot,et al.  Tackling health inequalities in the United Kingdom: the progress and pitfalls of policy. , 2003, Health services research.

[16]  俊郎 黒木,et al.  Centers for Disease Control and Prevention (CDC) ホームページの活用法 , 2002 .

[17]  J. Lazarus,et al.  HIV/AIDS in eastern Europe: more than a sexual health crisis. , 2006, Central European journal of public health.

[18]  S. Looney,et al.  Comparison of Incidence of Invasive Streptococcus pneumoniae Disease Among Children Before and After Introduction of Conjugated Pneumococcal Vaccine , 2005, The Pediatric infectious disease journal.

[19]  Elias Mossialos,et al.  Funding Health Care: Options for Europe , 2002 .

[20]  Elizabeth Miller,et al.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction , 2004, The Lancet.